AB-180 PTVA
AB-180 PTVA
AB-180 Percutaneous Transseptal Ventricular Assist System for Cardiogenic Shock. A trial that assessed the safety/feasibility of the AB-180 TandemHeart™ device for stabilising patients with cardiogenic shock.Primary endpoints Haemodynamics, end-organ perfusion
Conclusion TandemHeart improves haemodynamics and end-organ perfusion in cardiogenic shock, and can be used as a best bridge to a next therapy.